🚀 VC round data is live in beta, check it out!
Arkema Valuation Multiples
Discover revenue and EBITDA valuation multiples for Arkema and similar public comparables like Wacker Chemie, Fuchs, Yansab, Croda International and more.
Arkema Overview
About Arkema
Arkema SA is a French chemical company formerly known for its large presence in the acrylics market. However, the company has now developed a strong portfolio of speciality materials. Arkema is organized into four segments. Adhesive solutions, advanced materials, and coatings solutions contain the more specialized material businesses. The intermediates segment houses the remaining commodity chemical businesses. Geographically, sales are split fairly equally among Europe, the US, and Asia.
Founded
2003
HQ
Employees
21.1K
Website
Sectors
Financials (LTM)
EV
$8B
Arkema Financials
Arkema reported last 12-month revenue of $11B and EBITDA of $1B.
In the same LTM period, Arkema generated $1B in EBITDA and $107M in net income.
Revenue (LTM)
Arkema P&L
In the most recent fiscal year, Arkema reported revenue of $11B and EBITDA of $1B.
Arkema expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $11B | XXX | $11B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | — | XXX | 18% | XXX | XXX | XXX |
| EBITDA | $1B | XXX | $1B | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $107M | XXX | $74M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Arkema Stock Performance
Arkema has current market cap of $5B, and enterprise value of $8B.
Market Cap Evolution
Arkema's stock price is $72.17.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8B | $5B | 3.3% | XXX | XXX | XXX | $0.98 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialArkema Valuation Multiples
Arkema trades at 0.8x EV/Revenue multiple, and 5.6x EV/EBITDA.
EV / Revenue (LTM)
Arkema Financial Valuation Multiples
As of April 18, 2026, Arkema has market cap of $5B and EV of $8B.
Equity research analysts estimate Arkema's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Arkema has a P/E ratio of 51.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV (current) | $8B | XXX | $8B | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 5.6x | XXX | 5.6x | XXX | XXX | XXX |
| EV/EBIT | 12.6x | XXX | 12.4x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.3x | XXX | XXX | XXX |
| P/E | 51.0x | XXX | 73.5x | XXX | XXX | XXX |
| EV/FCF | 21.7x | XXX | 19.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Arkema Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Arkema Margins & Growth Rates
Arkema's revenue in the last 12 month grew by 1%.
Arkema's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Arkema's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Arkema's rule of X is 16% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Arkema Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | (0%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 13% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Arkema Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Arkema | XXX | XXX | XXX | XXX | XXX | XXX |
| Wacker Chemie | XXX | XXX | XXX | XXX | XXX | XXX |
| Fuchs | XXX | XXX | XXX | XXX | XXX | XXX |
| Yansab | XXX | XXX | XXX | XXX | XXX | XXX |
| Croda International | XXX | XXX | XXX | XXX | XXX | XXX |
| Balchem | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Arkema M&A Activity
Arkema acquired XXX companies to date.
Last acquisition by Arkema was on XXXXXXXX, XXXXX. Arkema acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Arkema
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialArkema Investment Activity
Arkema invested in XXX companies to date.
Arkema made its latest investment on XXXXXXXX, XXXXX. Arkema invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Arkema
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Arkema
| When was Arkema founded? | Arkema was founded in 2003. |
| Where is Arkema headquartered? | Arkema is headquartered in France. |
| How many employees does Arkema have? | As of today, Arkema has over 21K employees. |
| Who is the CEO of Arkema? | Arkema's CEO is Thierry Le Henaff. |
| Is Arkema publicly listed? | Yes, Arkema is a public company listed on Euronext Paris. |
| What is the stock symbol of Arkema? | Arkema trades under AKE ticker. |
| When did Arkema go public? | Arkema went public in 2006. |
| Who are competitors of Arkema? | Arkema main competitors are Wacker Chemie, Fuchs, Yansab, Croda International. |
| What is the current market cap of Arkema? | Arkema's current market cap is $5B. |
| What is the current revenue of Arkema? | Arkema's last 12 months revenue is $11B. |
| What is the current revenue growth of Arkema? | Arkema revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Arkema? | Current revenue multiple of Arkema is 0.8x. |
| Is Arkema profitable? | Yes, Arkema is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Arkema? | Arkema's last 12 months EBITDA is $1B. |
| What is Arkema's EBITDA margin? | Arkema's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Arkema? | Current EBITDA multiple of Arkema is 5.6x. |
| What is the current FCF of Arkema? | Arkema's last 12 months FCF is $380M. |
| What is Arkema's FCF margin? | Arkema's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Arkema? | Current FCF multiple of Arkema is 21.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.